These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
625 related articles for article (PubMed ID: 34958385)
1. Phytolectin nanoconjugates in combination with standard antifungals curb multi-species biofilms and virulence of vulvovaginal candidiasis (VVC) causing Candida albicans and non-albicans Candida. Senthilganesh J; Kuppusamy S; Durairajan R; Subramaniyan SB; Veerappan A; Paramasivam N Med Mycol; 2022 Jan; 60(2):. PubMed ID: 34958385 [TBL] [Abstract][Full Text] [Related]
2. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis. Gao M; Wang H; Zhu L Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337 [TBL] [Abstract][Full Text] [Related]
3. Vulvovaginal candidiasis and asymptomatic vaginal colonization in Portugal: Epidemiology, risk factors and antifungal pattern. Fernandes Â; Azevedo N; Valente A; Dias M; Gomes A; Nogueira-Silva C; Henriques M; Silva S; Gonçalves B Med Mycol; 2022 May; 60(5):. PubMed ID: 35482711 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates. Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724 [TBL] [Abstract][Full Text] [Related]
5. Prevalence, antifungal susceptibility and etiology of vulvovaginal candidiasis in sub-Saharan Africa: a systematic review with meta-analysis and meta-regression. Mushi MF; Olum R; Bongomin F Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35781514 [TBL] [Abstract][Full Text] [Related]
6. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis. Hacioglu M; Guzel CB; Savage PB; Tan ASB Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682 [TBL] [Abstract][Full Text] [Related]
7. Analysis of Biofilm-Related Genes and Antifungal Susceptibility Pattern of Vaginal Mohammadi F; Hemmat N; Bajalan Z; Javadi A Biomed Res Int; 2021; 2021():5598907. PubMed ID: 34136569 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of citrus pectin capped copper sulfide nanoparticles against Candidiasis causing Candida biofilms. Al-Enazi NM; Alsamhary K; Ameen F Environ Res; 2023 May; 225():115599. PubMed ID: 36898420 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and species distribution of microorganisms isolated among non-pregnant women affected by vulvovaginal candidiasis: A retrospective study over a 20 year-period. Intra J; Sala MR; Brambilla P; Carcione D; Leoni V J Mycol Med; 2022 Aug; 32(3):101278. PubMed ID: 35523109 [TBL] [Abstract][Full Text] [Related]
11. Plasma-based strategy for inhibiting Candida albicans growth and CaMCA1 gene expression in vitro and reducing fungal pathogenicity in a murine model of vulvovaginal candidiasis. Ebrahimi-Shaghaghi F; Atyabi SM; Razzaghi-Abyaneh M Med Mycol; 2021 Dec; 60(1):. PubMed ID: 34694384 [TBL] [Abstract][Full Text] [Related]
12. Novel thiazolinyl-picolinamide-based palladium(II) complex extenuates the virulence and biofilms of vulvovaginal candidiasis (VVC) causing Candida. Gayatri M; Jothipandiyan S; Azeez MKA; Sudharsan M; Suresh D; Nithyanand P Int Microbiol; 2024 Oct; 27(5):1527-1539. PubMed ID: 38467906 [TBL] [Abstract][Full Text] [Related]
13. Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections. Scarsini M; Tomasinsig L; Arzese A; D'Este F; Oro D; Skerlavaj B Peptides; 2015 Sep; 71():211-21. PubMed ID: 26238597 [TBL] [Abstract][Full Text] [Related]
14. Species and antifungal susceptibility profile of agents causing vulvovaginal candidiasis in a military population: a cross-sectional study. Trajano DTM; Melhem MSC; Takahashi JPF; Bonfietti LX; de Araújo MR; Corrêa VB; Araújo KBO; Barnabé V; Fernandes CG Med Mycol; 2023 Mar; 61(3):. PubMed ID: 36893795 [TBL] [Abstract][Full Text] [Related]
15. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy. Goswami D; Goswami R; Banerjee U; Dadhwal V; Miglani S; Lattif AA; Kochupillai N J Infect; 2006 Feb; 52(2):111-7. PubMed ID: 15908007 [TBL] [Abstract][Full Text] [Related]
16. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.]. Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of Lactobacillus casei Shirota against both Candida auris and Candida spp. isolates that cause vulvovaginal candidiasis and are resistant to antifungals. Paniágua AL; Correia AF; Pereira LC; de Alencar BM; Silva FBA; Almeida RM; de Medeiros Nóbrega YK BMC Complement Med Ther; 2021 Sep; 21(1):237. PubMed ID: 34556109 [TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology, antifungal susceptibility, and ERG11 gene mutation of Candida species isolated from vulvovaginal candidiasis: Comparison between recurrent and non-recurrent infections. Esfahani A; Omran AN; Salehi Z; Shams-Ghahfarokhi M; Ghane M; Eybpoosh S; Razzaghi-Abyaneh M Microb Pathog; 2022 Sep; 170():105696. PubMed ID: 35921954 [TBL] [Abstract][Full Text] [Related]
19. Virulence is one of the mechanisms of vulvovaginal candidiasis recurrence, rather than drug resistance. Li X; Chen S; Lyu X; Tian J Med Mycol; 2022 Nov; 60(11):. PubMed ID: 36328948 [TBL] [Abstract][Full Text] [Related]